PROACT Xa Trial of Apixaban With On-X Heart Valve Stopped

The DSMB cited a lack of evidence supporting noninferiority of apixaban over warfarin for valve thrombosis and thromboembolism.
Medscape Medical News

source https://www.medscape.com/viewarticle/981644?src=rss

Comments

Popular posts from this blog

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?